twozero Ventures
Istanbul, Turkey20
881K
14
5.00
2
0.30
- Stages of investment
- Areas of investment
Investor highlights
- Industry focus
- Stage focus
- Check size
- 50K — 2M
Discover reliable insights
Find relevant VC investors, identify key contacts and secure funding opportunities.
Investments analytics
Analytics
- Total investments
- 20
- Lead investments
- 2
- Rounds per year
- 5.00
- Follow on index
- 0.30
- Investments by industry
- Food and Beverage (4)
- SaaS (4)
- Artificial Intelligence (3)
- Software (3)
- Internet (3) Show 30 more
- Investments by region
- Turkey (12)
- United States (6)
- Peak activity year
- 2020
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 5
- Avg. valuation at time of investment
- 1M
- Group Appearance index
- 0.85
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| BluTV | 01 May 2020 | Internet, Video, Video on Demand, Video Streaming | Early Stage Venture | Istanbul, Istanbul, Turkey | |
| Ollang | 25 Mar 2023 | E-Commerce, Software, Artificial Intelligence, Marketplace, Media and Entertainment, Translation Service | Seed | 1M | United States, Delaware, Delaware City |
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| Hermes Biosciences | Nov 19, 2025 | Automated Technology, Clinical Innovation, Diagnostic Development, Life Science Tools, Research, Research and Diagnostic Development | Early stage | - |  San Francisco, California |
| Aqtual | Oct 7, 2025 | Cell-free DNA-based Platform, Chronic Disease Management, Oncology, Precision Medicine | - | 31000000 USD | Hayward, California |
| Alida Biosciences | Dec 6, 2024 | Bioinformatics, Epigenomic Research, Epitranscriptomics, RNA Modifications | Early stage | 7500000 USD | San Diego, California |
| BrightSpec | Dec 15, 2022 | Analytical Instruments, Computational Quantum Chemistry, Consumer and Beverage, Industrial Chemical, Life Science Tools, Pharmaceutical, Spectroscopic Technique | Growth stage | 18400000 USD | Charlottesville, Virginia |
| SimBioSys | Oct 27, 2021 | AI, Biophysical, Cancer Treatment, Drug Development, Precision Medicine, Simulation-based Platform | Early stage | 15000000 USD | Chicago, Illinois |
Similar funds
By same location
By same geo focus
By doing lead investments
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.